SIRT1, Polyphenols, and Endothelial Oxidants
SIRT1、多酚和内皮氧化剂
基本信息
- 批准号:8230873
- 负责人:
- 金额:$ 29.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosine5&apos-AMP-activated protein kinaseAMP-activated protein kinase kinaseAbbreviationsAccountingAcetyl-CoA CarboxylaseAdhesionsAdverse effectsAmino AcidsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntioxidantsApoptosisApoptoticAreaArterial Fatty StreakAtherosclerosisAttentionBindingBlood VesselsCa(2+)-Calmodulin Dependent Protein KinaseCaM kinase I activatorCalciumCaloric RestrictionCattleCell Adhesion MoleculesCellsChronicCysteineDetectionDiabetes MellitusDiabetic mouseDietDown-RegulationEndothelial CellsEndotheliumExposure toFatty acid glycerol estersFunctional disorderGlucoseHistone DeacetylaseHumanHyperlipidemiaInflammationInsulin ResistanceInsulin-Dependent Diabetes MellitusIntercellular adhesion molecule 1LabelLaboratoriesLeukocytesLongevityLow Density Lipoprotein ReceptorManganese Superoxide DismutaseMass Spectrum AnalysisMediatingMetabolic syndromeMethodsMusMutant Strains MiceNitric OxideNitrogenNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsOxidantsOxidation-ReductionOxygenPathway interactionsPeroxonitritePhosphotransferasesPost-Translational Protein ProcessingPredispositionProteinsRecombinantsResveratrolRoleSTK11 geneSignal TransductionSuperoxide DismutaseSuperoxidesTherapeutic EffectTissuesTyrosineUmbilical veinUp-RegulationVascular Cell Adhesion Molecule-1VasodilationWeightZincadenylate kinaseaortic archatherogenesisdimerfeedinghuman NOS2A proteinhuman NOS3 proteinimidazolecarboxamideloss of functionneurotensin mimic 1nitrationoxidant stressoxidationoxidized low density lipoproteinpolyphenolpreventprogramsred wineresponseribosidesarcoplasmic reticulum calcium ATPase
项目摘要
Increased oxidants are associated with insulin resistance, the metabolic syndrome, and a predisposition to
atherosclerosis. This laboratory has demonstrated that the increase in oxidants causes oxidative post-
translational modifications (OPTM) in key vascular cell proteins, including endothelial nitric oxide synthase
(eNOS), the sarcoplasmic reticulum calcium ATPase, p21ras, and manganese superoxide dismutase. These
OPTM including tyrosine nitration and cysteine sulfoxidation of specific amino acid residues have been
implicated in cellular dysfunction. In an example key to endothelial function, high glucose oxidizes the redox-
sensitive zinc thiolate that normally binds eNOS dimers, resulting in eNOS dysfunction. Our preliminary
studies have identified another potential oxidant target, sirtuin-1 (SIRT-1), a class III histone deacetylase that
is thought to be responsible for the increased life span caused by caloric restriction. Polyphenols, including
the red wine component, resveratrol, directly activate SIRT-1 and mimic the effects of caloric restriction, and
they have also recently been shown by others and us to reduce weight, hyperlipidemia, adhesion molecule
expression, oxidants, and atherosclerosis in fat-fed mice. We discovered that polyphenols stimulate AMP-
activated protein kinase (AMPK), and implicated AMPK in mediating improvements in hyperlipidemia and
atherosclerosis in diabetic mice. Together with other projects within this program, we now propose that
chronic oxidant stress associatedwith the metabolic syndrome can directly target and inactivate
SIRT1, contributing to the down-regulation of AMPK activity and endothelial dysfunction observed in
the metabolic syndrome. In addition, we propose that polyphenols stimulate SIRT1/LKB1/AMPK/
eNOS signaling to maintain endothelial function, decrease oxidants, and suppressadhesion
molecule expression, apoptosis, and atherogenesis. Our aims are to determine, 1) the role of down- and
up-regulation of SIRT1/LKB1/ AMPK/eNOS signaling in mediating the effect of oxidants and the response to
polyphenols, 2) what OPTM occur in SIRT-1 during exposure to oxidants, and 3) the role of SIRT1,LKB1
and eNOS in the therapeutic effect of polyphenols on inflammation, oxidants, and atherogenesis in fat-fed
mice.
增加的氧化剂与胰岛素抵抗,代谢综合征以及对
动脉粥样硬化。该实验室表明,氧化剂的增加会导致氧化后 -
关键血管细胞蛋白中的翻译修饰(OPTM),包括内皮一氧化氮合酶
(eNOS),肌质网钙ATPase,P21RA和锰超氧化物歧化酶。这些
OPTM包括特异性氨基酸残基的酪氨酸硝化和半胱氨酸磺酸一词已是
与细胞功能障碍有关。在一个示例的内皮功能的钥匙中,高葡萄糖氧化了氧化还原
敏感的硫代锌通常结合eNOS二聚体,从而导致eNOS功能障碍。我们的初步
研究已经确定了另一个潜在的氧化剂靶标SIRTUIN-1(SIRT-1),这是一种III类组蛋白脱乙酰基酶
被认为是由热量限制引起的寿命增加的原因。多酚,包括
红酒成分,白藜芦醇,直接激活SIRT-1并模仿热量限制的影响,并
最近,其他人也证明了它们,以减轻体重,高脂血症,粘附分子
脂肪喂养小鼠的表达,氧化剂和动脉粥样硬化。我们发现多酚刺激了AMP-
活化的蛋白激酶(AMPK),并与AMPK有关介导高脂血症和
糖尿病小鼠的动脉粥样硬化。与该计划中的其他项目一起,我们现在建议
与代谢综合征有关的慢性氧化剂应力与代谢综合征可以直接靶向并失活
SIRT1,导致AMPK活性下调和内皮功能障碍在
代谢综合征。此外,我们建议多酚刺激SIRT1/LKB1/AMPK/
eNOS信号传导以维持内皮功能,降低氧化剂和抑制添加
分子表达,凋亡和动脉粥样硬化。我们的目的是确定,1)下调和
SIRT1/LKB1/AMPK/ENOS信号的上调在介导氧化剂的作用和对响应的响应中
多酚,2)暴露于氧化剂期间SIRT-1中发生的选择,3)SIRT1,LKB1的作用
以及多酚对脂肪喂养的炎症,氧化剂和动脉粥样硬化的治疗作用中的eNOS
老鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD A COHEN其他文献
RICHARD A COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD A COHEN', 18)}}的其他基金
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY
通过质谱法鉴定含氧化剂敏感半胱氨酸的蛋白质
- 批准号:
8365499 - 财政年份:2011
- 资助金额:
$ 29.99万 - 项目类别:
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES
氧化应激下人类 H-RAS 的 PTM 作图
- 批准号:
8365567 - 财政年份:2011
- 资助金额:
$ 29.99万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8109964 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
7947453 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8484428 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8149954 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8294637 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8292165 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES
氧化应激下人类 H-RAS 的 PTM 作图
- 批准号:
8170941 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8699256 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
相似国自然基金
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
- 批准号:81300507
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the mechanism of erythropoietin (EPO) in mitigating Dry-AMD pathophysiology
阐明促红细胞生成素 (EPO) 缓解干性 AMD 病理生理学的机制
- 批准号:
10521937 - 财政年份:2022
- 资助金额:
$ 29.99万 - 项目类别:
Dose Ranging study of the Effects of Alpha Acid on Oxidative Stress
α酸对氧化应激影响的剂量范围研究
- 批准号:
7896471 - 财政年份:2008
- 资助金额:
$ 29.99万 - 项目类别: